Atlas Trials

Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Clinical trial NCT02120196 · UNKNOWN

Trial details

NCT number
NCT02120196
Sponsor
Sherief Abd-Elsalam
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Spontaneous Bacterial PeritonitisAscitesLiver Cirrhosis
Start date
2014-01-01
Primary completion
2023-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.